These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 36528186)

  • 1. Lutein-loaded nanoparticles reverse oxidative stress, apoptosis, and autism spectrum disorder-like behaviors induced by prenatal valproic acid exposure in female rats.
    Viana CE; Bortolotto VC; Araujo SM; Dahleh MMM; Machado FR; de Souza Pereira A; Moreira de Oliveira BP; Leimann FV; Gonçalves OH; Prigol M; Guerra GP
    Neurotoxicology; 2023 Jan; 94():223-234. PubMed ID: 36528186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neuroprotective effect of Diosgenin in the rat Valproic acid model of autism.
    Reza Naghdi M; Ahadi R; Motamed Nezhad A; Sadat Ahmadi Tabatabaei F; Soleimani M; Hajisoltani R
    Brain Res; 2024 Sep; 1838():148963. PubMed ID: 38705555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin A supplementation ameliorates prenatal valproic acid-induced autism-like behaviors in rats.
    Liu Z; Wang J; Xu Q; Wu Z; You L; Hong Q; Zhu J; Chi X
    Neurotoxicology; 2022 Jul; 91():155-165. PubMed ID: 35594946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.
    Mirza R; Sharma B
    Brain Res Bull; 2019 Apr; 147():36-46. PubMed ID: 30769127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin A ameliorates valproic acid-induced autism-like symptoms in developing zebrafish larvae by attenuating oxidative stress and apoptosis.
    Wang J; Zou L; Jiang P; Yao M; Xu Q; Hong Q; Zhu J; Chi X
    Neurotoxicology; 2024 Mar; 101():93-101. PubMed ID: 38191030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of early handling on anxiety-like behaviors of rats exposed to valproic acid pre-and post-natally.
    Shafaghi A; Vakili Shahrbabaki SS; Aminzadeh A; Heidari MR; Shamsi Meymandi M; Bashiri H
    Neurotoxicol Teratol; 2022; 89():107050. PubMed ID: 34801733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ameliorating effect of pioglitazone on prenatal valproic acid-induced behavioral and neurobiological abnormalities in autism spectrum disorder in rats.
    Sandhu A; Rawat K; Gautam V; Bhatia A; Grover S; Saini L; Saha L
    Pharmacol Biochem Behav; 2024 Apr; 237():173721. PubMed ID: 38307465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphodiesterase inhibitor, ibudilast alleviates core behavioral and biochemical deficits in the prenatal valproic acid exposure model of autism spectrum disorder.
    Sandhu A; Rawat K; Gautam V; Sharma A; Kumar A; Saha L
    Brain Res; 2023 Sep; 1815():148443. PubMed ID: 37290608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prangos ferulacea (L.) ameliorates behavioral alterations, hippocampal oxidative stress markers, and apoptotic deficits in a rat model of autism induced by valproic acid.
    Saadat M; Taherian AA; Aldaghi MR; Raise-Abdullahi P; Sameni HR; Vafaei AA
    Brain Behav; 2023 Nov; 13(11):e3224. PubMed ID: 37596045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorder.
    Luhach K; Kulkarni GT; Singh VP; Sharma B
    J Pharm Pharmacol; 2021 Oct; 73(11):1460-1469. PubMed ID: 34459916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effect of the standardised extract of Bacopa monnieri (BacoMind) in valproic acid model of autism spectrum disorder in rats.
    Abhishek M; Rubal S; Rohit K; Rupa J; Phulen S; Gurjeet K; Raj SA; Manisha P; Alka B; Ramprasad P; Bikash M
    J Ethnopharmacol; 2022 Jul; 293():115199. PubMed ID: 35346813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics and prebiotics alleviate behavioral deficits, inflammatory response, and gut dysbiosis in prenatal VPA-induced rodent model of autism.
    Adıgüzel E; Çiçek B; Ünal G; Aydın MF; Barlak-Keti D
    Physiol Behav; 2022 Nov; 256():113961. PubMed ID: 36100109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of pioglitazone, a selective peroxisome proliferator-activated receptor-γ agonist in prenatal valproic acid-induced behavioral and biochemical autistic like features in Wistar rats.
    Mirza R; Sharma B
    Int J Dev Neurosci; 2019 Aug; 76():6-16. PubMed ID: 31128204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effect of atorvastatin and risperidone on modulation of TLR4/NF-κB/NOX-2 in a rat model of valproic acid-induced autism.
    Farrag EAE; Askar MH; Abdallah Z; Mahmoud SM; Abdulhai EA; Abdelrazik E; Nashar EME; Alasiri FM; Alqahtani ANS; Eldesoqui M; Eldib AM; Magdy A
    Behav Brain Funct; 2024 Sep; 20(1):26. PubMed ID: 39350139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of prenatal versus postnatal valproic acid rat models of autism: A behavioral and neurobiological study.
    Elnahas EM; Abuelezz SA; Mohamad MI; Nabil MM; Abdelraouf SM; Bahaa N; Hassan GA; Ibrahim EA; Ahmed AI; Aboul-Fotouh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110185. PubMed ID: 33238165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral edaravone ameliorates behavioral deficits and pathologies in a valproic acid-induced rat model of autism spectrum disorder.
    Lu XY; Li MQ; Li YT; Yao JY; Zhang LX; Zeng ZH; Yu-Liu ; Chen ZR; Li CQ; Zhou XF; Li F
    Neuropharmacology; 2024 Nov; 258():110089. PubMed ID: 39033904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-aminolevulinic acid inhibits oxidative stress and ameliorates autistic-like behaviors in prenatal valproic acid-exposed rats.
    Matsuo K; Yabuki Y; Fukunaga K
    Neuropharmacology; 2020 May; 168():107975. PubMed ID: 31991146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic inhibition of astrocytic aquaporin-4 induces autistic-like behavior in control rat offspring similar to maternal exposure to valproic acid.
    Davoudi S; Rahdar M; Hosseinmardi N; Behzadi G; Janahmadi M
    Physiol Behav; 2023 Oct; 269():114286. PubMed ID: 37402416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel potential of metformin on valproic acid-induced autism spectrum disorder in rats: involvement of antioxidant defence system.
    Ishola IO; Balogun AO; Adeyemi OO
    Fundam Clin Pharmacol; 2020 Dec; 34(6):650-661. PubMed ID: 32415700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syringic acid alleviates valproic acid induced autism via activation of p38 mitogen-activated protein kinase: Possible molecular approach.
    Mallan S; Singh S
    Environ Toxicol; 2023 Oct; 38(10):2400-2415. PubMed ID: 37357844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.